跳至主要内容
临床试验/EUCTR2005-004135-22-DE
EUCTR2005-004135-22-DE进行中(未招募)不适用

Multicenter phase II study with docetaxel, 5-FU, leucovorin, and oxaliplatin in patients with metastatic or locally advanced gastric cancer or cancer of the esophagogastric junction- FLOT

Krankenhaus Nordwest0 个研究点目标入组 42 人开始时间: 2005年11月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with advanced gastric cancer
  • Sufficient bone marrow and organ function
  • Age >= 18 years; women and men
  • ECOG 0, 1, or 2
  • written informed concent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Known allergy to any study drug
  • Participation at another clinical investigation
  • Severe concurrent illness

研究者

发起方
Krankenhaus Nordwest

相似试验